-
$0
0.0% of portfolio
-
Q4 2024
Reduced 56.46%
$0
$27,000
0.0% of portfolio
2,230
Q3 2023
New
Morgan Stanley Direct Lendin
-
$0
0.0% of portfolio
-
Q4 2024
Added 100.0%
$0
$131,000
0.0% of portfolio
28,970
Q4 2024
Added 26.18%
$0
$30,000
0.0% of portfolio
4,000
Q3 2023
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 201.93%
-
$0
0.0% of portfolio
-
Q4 2024
Added 126.94%
-
$0
0.0% of portfolio
-
Q4 2024
Added 1,356.96%
Morgan Stanley Pathway Fds
-
$0
0.0% of portfolio
-
Q4 2024
New
Morgan Stanley Pathway Fds
-
$0
0.0% of portfolio
-
Q4 2024
New
$9.61B
$1.2 Million
0.0% of portfolio
48,901
Q4 2024
Reduced 15.07%
$403M
$15,000
0.0% of portfolio
781
Q4 2024
Reduced 66.5%
$4.6B
$744,000
0.0% of portfolio
47,751
Q4 2024
Reduced 30.12%
$996M
$878,000
0.0% of portfolio
68,760
Q4 2024
Added 140.87%
$4.2B
$71,000
0.0% of portfolio
3,169
Q4 2024
Reduced 24.4%
$440M
$6,000
0.0% of portfolio
612
Q4 2024
Reduced 95.51%
$2.11B
$886,000
0.0% of portfolio
5,961
Q4 2024
Reduced 6.08%
$807M
$448,000
0.0% of portfolio
32,747
Q4 2024
Reduced 7.16%
$1.35B
$260,000
0.0% of portfolio
27,940
Q4 2024
Added 14.67%
$197M
$1,000
0.0% of portfolio
45
Q4 2024
Reduced 33.82%
$879M
$225,000
0.0% of portfolio
6,337
Q4 2024
Reduced 2.55%
$385M
$3,000
0.0% of portfolio
44
Q3 2023
New
$163M
$1,000
0.0% of portfolio
46
Q4 2024
Reduced 79.28%
$3.65B
$378,000
0.0% of portfolio
8,875
Q4 2024
Reduced 9.96%
$1.49B
$560,000
0.0% of portfolio
13,008
Q4 2024
Reduced 2.36%
-
$0
0.0% of portfolio
-
Q4 2024
Added 21.42%
$1.41B
$457,000
0.0% of portfolio
4,253
Q4 2024
Reduced 2.18%
$631M
$180,000
0.0% of portfolio
1,831
Q4 2024
Reduced 12.35%
$1.03B
$285,000
0.0% of portfolio
27,359
Q4 2024
Reduced 0.47%
-
$0
0.0% of portfolio
-
Q3 2024
New
$267M
$0
0.0% of portfolio
5
Q2 2024
Reduced 89.13%
$857M
$5,000
0.0% of portfolio
145
Q3 2023
New
$1.36B
$222,000
0.0% of portfolio
2,002
Q3 2024
Reduced 74.98%
Natures Sunshine Prods Inc
-
$0
0.0% of portfolio
-
Q3 2023
New
$123M
$2,000
0.0% of portfolio
1,209
Q4 2023
Reduced 31.46%
$1.81B
$564,000
0.0% of portfolio
42,444
Q4 2024
Reduced 2.47%
$1.83B
$792,000
0.0% of portfolio
16,594
Q4 2024
Reduced 1.65%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.09%
$2.97B
$2,000
0.0% of portfolio
26
Q4 2024
Reduced 35.0%
$1.24B
$830,000
0.0% of portfolio
50,398
Q4 2024
Reduced 2.67%
$142M
$1,000
0.0% of portfolio
1,107
Q3 2024
Added 351.84%
$679M
$3,000
0.0% of portfolio
140
Q4 2024
Reduced 89.16%
$1.53B
$959,000
0.0% of portfolio
44,300
Q4 2024
Reduced 2.36%
$756M
$137,000
0.0% of portfolio
9,703
Q4 2024
Added 174.33%
$0
$112,000
0.0% of portfolio
12,762
Q4 2024
Added 16.16%
$0
$40,000
0.0% of portfolio
5,445
Q4 2024
Added 1.57%
$0
$103,000
0.0% of portfolio
8,067
Q4 2024
Reduced 13.88%
$0
$0
0.0% of portfolio
11
Q1 2024
Reduced 81.36%
Neumora Therapeutics Inc.
-
$0
0.0% of portfolio
-
Q4 2024
New